The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
PRIORITY CLAIM
This application is a .ANG.371 application of PCT/US2005/023012 that was filed on Jun. 27, 2005, which claims priority from the U.S. Provisional Application No. 60/584,804, filed on Jul. 1, 2004, now expired.
